Nalmefene (Selincro) orally
Journal de Pharmacie de Belgique 2014(4): 51-52
2014
ISSN/ISBN: 0047-2166 PMID: 25562928 Document Number: 671624
Document emailed within 1 workday
Related Documents
Michel, M.E.; Bolger, G.; Weissman, B.A. 1985: Binding of a new opiate antagonist, nalmefene, to rat brain membranes Methods and Findings in Experimental and Clinical Pharmacology 7(4): 175-177Lopez, J.; Naujokat, P.; Xavier, R.; Walters, W.; Toledo-Pereyra, L.H. 1991: Protective effect of nalmefene and naloxone on the ischemically damaged small bowel Transplantation Proceedings 23(5): 2448-2449
Glover, H. 1993: A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder Israel Journal of Psychiatry and Related Sciences 30(4): 255-263
Herzog, J.L.; Solomon, J.A.; Draelos, Z.; Fleischer, A.; Stough, D.; Wolf, D.I.; Abramovits, W.; Werschler, W.; Green, E.; Duffy, M.; Rothaul, A.; Tansley, R. 2011: A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 853-860
Gisclon, L.G.; Ayres, J.W.; Ewing, G.H. 1979: Pharmacokinetics of orally administered dyphylline American Journal of Hospital Pharmacy 36(9): 1179-1184
Lampe, C.E. 1971: Effects of orally administered Dulcolax Nordisk Medicin 85(15): 478-479
Lefebvre, P. 1987: Benefits and mishaps of orally-induced hyperglycemia Journees Annuelles de Diabetologie de l'Hotel-Dieu 1987: 313-322
Huisman, J. 1984: Vaccination against abdominal typhus: subcutaneously or orally? Nederlands Tijdschrift Voor Geneeskunde 128(30): 1425-1427
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic effects of orally-administered hexobendine Wiener Klinische Wochenschrift 84(7): 112-114
Okabe, H.; Saito, H.; Oie, S.; Nakano, K.; Uchida, J.; Takechi, T.; Takeda, S.; Kawaguchi, Y.; Taguchi, T. 1991: Combination chemotherapy with orally administered UFT and leucovorin (LV) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(10): 1645-1650
Sohr, R.; Matthias, M.; Brockmann, B.; Preiss, R. 1983: Absorption of high doses of cyclophosphamide given orally Die Pharmazie 38(6): 425-426
Hartig, W.; Czarnetzki, H.D.; Faust, H.; Martin, H.; Martin, R.; Wetzel, K. 1979: The human utilization of orally administered 15N-glycine Infusionstherapie und Klinische Ernahrung 6(1): 6-9
Nelson, A.L. 2015: An update on new orally administered contraceptives for women Expert Opinion on PharmacoTherapy 16(18): 2759-2772
Wilke, D. 2014: Is high-dose, orally administered alendronate analgesic? Medizinische Monatsschrift für Pharmazeuten 37(12): 459-460
Menczel, J.; Rosoff, B.; Spencer, H. 1982: Tissue distribution of orally administered 91Y and 46Sc in mice Health Physics 42(5): 727-730
Ricci, G.; Copaitich, T. 1954: Elimination of orally administered isoniazid in human milk La Rassegna di Clinica Terapia e Scienze Affini 53(4): 209-214
Kochak, G.M.; Rakhit, A. 1987: Determination of metabolite pharmacokinetics for orally administered prodrugs Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(4): 456-459
Nilsson, A.; Melin, T. 1988: Absorption and metabolism of orally fed arachidonic and linoleic acid in the rat American Journal of Physiology 255(5 Pt 1): G612-G618
Hahn, D.W.; Allen, G.O.; McGuire, J.L. 1977: The pharmacological profile of norgestimate, a new orally active progestin Contraception 16(5): 541-553
Roussaux, J.P.; Derely, M.; Hers, D. 1989: Potassium chlorazepate administered orally in alcoholic detoxification Journal de Pharmacie de Belgique 44(3): 192-196